SEMMAX FINANCIAL ADVISORS INC. BioCryst Pharmaceuticals, Inc. Transaction History

SEMMAX FINANCIAL ADVISORS INC. portfolio value:

$22,000
portfolio value

SEMMAX FINANCIAL ADVISORS INC. quarter portfolio value change:

+19.09%
quarter

BioCryst Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -5K $12.6 1.84K
Q2 2022 share Increase +8.83% 150 shares -1K $10.58 1.84K
Q1 2022 share Increase +389.63% 1.35K shares 23K $16.26 1.69K
Q4 2021 share 0.00% 0 shares 0 $13.79 347
Q3 2021 share Increase 0.00% 347 shares 5K $14.37 347